IL-33 Antikörper
(1 reference)-
- Target Alle IL-33 (IL33) Antikörper anzeigen
- IL-33 (IL33) (Interleukin 33 (IL33))
-
Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser IL-33 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA, Immunohistochemistry (IHC), Immunoprecipitation (IP), Functional Studies (Func)
- Spezifität
- Recognizes human IL-33.
- Kreuzreaktivität
- Human
- Keine Kreuzreaktivität
- Maus
- Kreuzreaktivität (Details)
- Does not cross-react with mouse IL-33.
- Sterilität
- 0.2 μm filtered
- Immunogen
- Recombinant human IL-33.
- Klon
- IL33305B
- Isotyp
- IgG2a
- Top Product
- Discover our top product IL33 Primärantikörper
-
anti-Interleukin 33 (IL33) (AA 112-270) antibody
IL33 Reaktivität: Human WB, IHC, IP, ICC Wirt: Maus Monoclonal C11 unconjugated
anti-Interleukin 33 (IL33) antibodyIL33 Reaktivität: Human WB, ELISA, IHC, IP, Func Wirt: Maus Monoclonal IL33305B unconjugated
anti-Interleukin 33 (IL33) (AA 110-261) antibodyIL33 Reaktivität: Ratte WB, IHC, IP, ICC Wirt: Maus Monoclonal 2# unconjugated
anti-Interleukin 33 (IL33) (AA 185-264) antibodyIL33 Reaktivität: Maus, Ratte ELISA, FACS, IHC (p), IF (p), IF (cc), IHC (fro) Wirt: Kaninchen Polyclonal unconjugated
anti-Interleukin 33 (IL33) (AA 171-269) antibodyIL33 Reaktivität: Human WB, ELISA Wirt: Maus Monoclonal 2D8 unconjugated
anti-Interleukin 33 (IL33) (AA 102-264) antibodyIL33 Reaktivität: Maus, Ratte WB, ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Interleukin 33 (IL33) antibodyIL33 Reaktivität: Human WB, IHC (p), EIA, Func Wirt: Kaninchen Polyclonal unconjugated
anti-Interleukin 33 (IL33) antibody (Biotin)IL33 Reaktivität: Human WB, EIA Wirt: Kaninchen Polyclonal Biotin
anti-Interleukin 33 (IL33) antibodyIL33 Reaktivität: Human WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Interleukin 33 (IL33) (AA 123-276) antibodyIL33 Reaktivität: Human ELISA, IHC, IF Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- Lot specific
- Buffer
- 0.2μm-filtered solution in PBS, pH 7.4. Contains no preservatives.
- Konservierungsmittel
- Without preservative
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
-
Short Term Storage: +4°C
Long Term Storage: -20°C
Stable for at least 1 year after receipt when stored at -20°C. - Haltbarkeit
- 12 months
-
-
: "Cigarette smoke alters IL-33 expression and release in airway epithelial cells." in: Biochimica et biophysica acta, Vol. 1842, Issue 9, pp. 1630-7, (2014) (PubMed).
-
: "Cigarette smoke alters IL-33 expression and release in airway epithelial cells." in: Biochimica et biophysica acta, Vol. 1842, Issue 9, pp. 1630-7, (2014) (PubMed).
-
- Target
- IL-33 (IL33) (Interleukin 33 (IL33))
- Andere Bezeichnung
- IL-33 (IL33 Produkte)
- Synonyme
- IL33 antikoerper, C9orf26 antikoerper, DVS27 antikoerper, IL1F11 antikoerper, NF-HEV antikoerper, NFEHEV antikoerper, RP11-575C20.2 antikoerper, 9230117N10Rik antikoerper, Il-33 antikoerper, Il1f11 antikoerper, RGD1311155 antikoerper, interleukin 33 antikoerper, IL33 antikoerper, Il33 antikoerper
- Hintergrund
- Interleukin-33 (IL-33, HF-NEV, IL-1F11), a member of the IL-1 family of cytokines, is expressed by many cell types following pro-inflammatory stimulation and is thought to be released on cell lysis. The 30 kDa human IL33 is converted by CASP1 to a 18 kDa protein. IL33 binds to and signals through ST2 (IL1R1) and its stimulation recruits MYD88, IRAK, IRAK4, and TRAF6, followed by phosphorylation of ERK1 (MAPK3)/ERK2 (MAPK1), p38(MAPK14), and JNK. The ability of IL-33 to target numerous immune cell types, like Th2-like cells, mast cells, and B1 cells, and to induce cytokine and chemokine production underlines its potential in influencing the outcome of a wide range of diseases, such as arthritis, asthma, atopic allergy & anaphylaxis, cardiovascular disease/atherosclerosis, nervous system diseases, and sepsis.
- UniProt
- O95760
- Pathways
- Production of Molecular Mediator of Immune Response
-
